ARTA
CARM

A.R.T. Advisors’s Carisma Therapeutics CARM Stock Holding History

A.R.T. Advisors’s Portfolio CARM Stock Details CARM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-755
Closed -$11K – 100
2020
Q2 		$11K Buy
+755
New +$10.2K 0.02% 270
2020
Q1 		– Sell
-2,795
Closed -$58K – 196
2019
Q4 		$58K Buy
+2,795
New +$64.2K ﹤0.01% 1245
2019
Q2 		– Sell
-3,318
Closed -$68K – 1365
2019
Q1 		$68K Buy
+3,318
New +$57.3K ﹤0.01% 1202
2017
Q3 		– Sell
-2,482
Closed -$77K – 1369
2017
Q2 		$77K Buy
+2,482
New +$82.8K ﹤0.01% 1276
2016
Q4 		– Sell
-665
Closed -$37K – 1288
2016
Q3 		$37K Buy
+665
New +$49.5K 0.01% 604

Other funds holding CARM

TG
TRV GP Boston, Massachusetts $18.9M AUM 541.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
KCM
Kingdon Capital Management New York $597M AUM 51.11% 1-Year Est. Return
EP
Eversept Partners New York $1.52B AUM 121.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $70.4B AUM 20.22% 1-Year Est. Return